FormWeb • lovotibeglogene autotemcel

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

lovotibeglogene autotemcel

lovotibeglogene autotemcel

Non-formulary Anti-Neoplastic Formulary

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Lyfgenia	SUSPENSION, INTRAVENOUS	1.7 to 20 × 10<sup>6</sup> CD34+ cells/mL

VIEW MORE Cellular and Gene Therapy

Comments:

Non-formulary. Defer initiation to a medical center that specializes in stem cell transplant.

Reviewed: May 2024

Lovotibeglogene autotemcel (LYFGENIA)

Last updated: Feb. 21, 2026

Black Box Warning: Hematologic Malignancy

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.